MC

Mallabanavadi Channabasavaiah Dayananda

Active Director Designated Partner DIN 10503753
DIN 10503753 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mallabanavadi Channabasavaiah Dayananda

Data last updated:

Mallabanavadi Channabasavaiah Dayananda is a Designated Partner at Cutis Medi Apparels Llp (since 2024).

DIN 10503753
Primary Designation Designated Partner
First Appointment 11 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Feb 20242024Active

Board colleagues of Mallabanavadi Channabasavaiah Dayananda

NameDINCompanyDesignation
Byalakere Shivanna Chandrashekar09460657Cutis Medi Apparels LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cutis Medi Apparels Llp
Premium access

Shareholding and investment profile for Mallabanavadi Channabasavaiah Dayananda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mallabanavadi Channabasavaiah Dayananda

Mallabanavadi Channabasavaiah Dayananda currently holds 1 directorship: Cutis Medi Apparels Llp (Designated Partner, since 11 Feb 2024).

Mallabanavadi Channabasavaiah Dayananda was first appointed on 11 Feb 2024 as Designated Partner at Cutis Medi Apparels Llp.

The current boards of Mallabanavadi Channabasavaiah Dayananda's companies include Byalakere Shivanna Chandrashekar (Cutis Medi Apparels Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available